Montague Markets Pharmacy

02/12/2025

The TGA has updated safety warnings for GLP-1 and GIP/GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro, Saxenda and Trulicity).

If you’re using these medications and have any concerns, please speak with our pharmacists or your GP.

If you or someone you know needs immediate mental health support, please contact:
💙 Lifeline: 13 11 14
💙 Su***de Call Back Service: 1300 659 467
💙 Beyond Blue: 1300 224 636
💙 Kids Helpline: 1800 551 800
💙 13 YARN: 13 92 76
💙 QLD Mental Health Access Line: 1300 MH CALL (1300 642 255)

⚠️ Product warnings updated for GLP-1 RA class⚠️

*Content advice – this post contains reference to su***de*

We have updated the product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues.

This relatively new and high-profile class of medicines is used to treat type 2 diabetes mellitus and/or obesity.

Medicines in the GLP-1 RA class currently marketed in Australia are:
• Ozempic (semaglutide)
• Wegovy (semaglutide)
• Saxenda (liraglutide)
• Trulicity (dulaglutide)
• Mounjaro (tirzepatide)

1. Potential risk of suicidal thoughts
Product warnings across the GLP-1 RA class of medicines have been aligned to ensure consistent information regarding the potential risk of suicidal thoughts or behaviours.

The updates follow investigations by TGA and other international regulators.

Patients taking any of these medicines should tell their health professional if they experience new or worsening depression, suicidal thoughts or any unusual changes in mood or behaviour.

If you or anyone you know needs help, call Lifeline on 13 11 14.

2. Mounjaro (tirzepatide) and contraception
Our investigation into the potential for reduced effectiveness of oral contraception when first taking or increasing the dose of Mounjaro (tirzepatide) has found that this association could not be ruled out.

As a precautionary measure, the product warnings for tirzepatide have been updated to include further advice for patients using oral contraceptives. Patients taking tirzepatide are advised to switch to a non-oral contraceptive or add a barrier method of contraception for 4 weeks after first taking the medicine and for 4 weeks after each increase in the dose.

None of the GLP-1 RAs should be used during pregnancy and individuals of childbearing potential are advised to use effective contraception during treatment with a GLP-1 RA.

Read more: https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/product-warnings-updated-glp-1-ra-class

28/07/2025

24/04/2025

Friendly reminder that we will be CLOSED on Friday 25th April for ANZAC Day. Normal trading hours resume on Saturday 26th April.

Lest We Forget.

📞 07 3051 0482
🌐 www.montaguemarketspharmacy.com.au

18/04/2025

Please note our altered trading hours for the Easter weekend:
🕒 Open Saturday 19th April: 8am – 5pm
🚪 Closed Good Friday, Easter Sunday & Easter Monday

Wishing all our wonderful customers a safe, happy, and relaxing Easter! Thank you for your continued support 💙

— Michael and the team at Montague Markets Pharmacy

30/03/2025

Flu vaccinations now available!! - book in-store or online at montaguemarketspharmacy.com.au

22/03/2025

💡 ICYMI: Two days ago, at , Prime Minister Anthony Albanese announced a reduction on the maximum out-of-pocket cost of prescription medicines for patients.

The new price of $25 will benefit over 20 million Australians who don’t hold a health or concession card.

Find out more 👉 https://loom.ly/6_rnb98

20/03/2025

We're excited to have some of our staff attending the Australian Pharmacy Professional Conference and Trade Exhibition, where they're gaining new skills and knowledge to improve our services for the West End community. Stay tuned for more updates over the weekend!